Bristol-Myers Squibb
BMY
$65.16
Share price
-0.49%
Change (1 day)
-14.92%
Change (1 year)
Categories
Bristol-Myers Squibb (BMY) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : $62.39 B
According to Bristol-Myers Squibb's latest financial reports the company's total liabilities are $62.39 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bristol-Myers Squibb - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $65.70 B | -10.38% |
| 2021-12-31 | $73.30 B | -9.05% |
| 2020-12-31 | $80.59 B | 3.01% |
| 2019-12-31 | $78.24 B | 275.12% |
| 2018-12-31 | $20.85 B | -3.89% |
| 2017-12-31 | $21.70 B | 25.02% |
| 2016-12-31 | $17.36 B | 0.21% |
| 2015-12-31 | $17.32 B | -7.68% |
| 2014-12-31 | $18.76 B | -19.65% |
| 2013-12-31 | $23.35 B | 4.93% |
| 2012-12-31 | $22.25 B | 30.15% |
| 2011-12-31 | $17.10 B | 10.79% |
| 2010-12-31 | $15.43 B | -4.84% |
| 2009-12-31 | $16.22 B | -6.29% |
| 2008-12-31 | $17.31 B | 10.9% |
| 2007-12-31 | $15.61 B | 0.17% |
| 2006-12-31 | $15.58 B | -7.95% |
| 2005-12-31 | $16.93 B | -16.32% |
| 2004-12-31 | $20.23 B | 14.41% |
| 2003-12-31 | $17.68 B | 11.18% |
| 2002-12-31 | $15.90 B | -2.54% |
| 2001-12-31 | $16.32 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $110.57 B | 77.22% | 🇺🇸 USA |
 Novartis NVS | $60.09 B | -3.68% | 🇨🇭 Switzerland |
 Pfizer PFE | $101.28 B | 62.34% | 🇺🇸 USA |
 AbbVie ABBV | $121.51 B | 94.76% | 🇺🇸 USA |
 Eli Lilly LLY | $41.86 B | -32.90% | 🇺🇸 USA |
 Amgen AMGN | $83.37 B | 33.62% | 🇺🇸 USA |
 Sanofi SNY | $55.23 B | -11.48% | 🇫🇷 France |
 Biogen BIIB | $10.81 B | -82.67% | 🇺🇸 USA |
 Merck MRK | $63.10 B | 1.13% | 🇺🇸 USA |
 AstraZeneca AZN | $60.87 B | -2.43% | 🇬🇧 UK |